Wu Bang-Cai, Xia Ji-Yi, Jiang Rui, Yang Hai-Fan
Department of Urology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China.
Zhonghua Nan Ke Xue. 2017 Feb;23(2):110-119.
To screen lentiviral vectors carrying siRNA which can specifically down-regulate the gene expression of the sphingosine-1-phosphate receptor 3 (S1PR3) in the corpus cavernosum smooth muscle (CCSM) cells of rats with spontaneous hypertension (SHT) and investigate the influence of the vectors on the signaling pathways of ROCK1, ROCK2 and eNOS in the CCSM cells of SHT rats.
Using the S1PR3 mRNA sequence of the rat as an interfering target, we designed and synthesized three pairs of siRNA sequences (siRNA1, 2 and 3) targeting S1PR3 and one pair of negative control, and then constructed and packaged them into lentiviral vectors. We cultured the CCSM cells of SHT and Wistar-Kyoto (WKY) rats in vitro and randomly divided them into groups A (SHT untransfected control), B (SHT transfected and carrying negative control virus), C (SHT transfected and carrying siRNA1 targeting S1PR3), D (SHT transfected and carrying siRNA2 targeting S1PR3), E (SHT transfected and carrying siRNA3 targeting S1PR3), and F (WKY untransfected control). With the multiplicity of infection (MOI) = 60, we transfected the CCSM cells of the SHT rats with the lentiviral vector and then determined the expression of the green fluorescent protein (GFP) as well as the mRNA and protein expressions of S1PR3, ROCK1, ROCK2 and eNOS in the CCSM cells of the SHT and WKY rats by RT-PCR and Western blot.
Gene sequencing proved the successful construction of the lentiviral vector. The transfection efficiency of the CCSM cells of the rats was >80% in groups B, C, D and E. Compared with group A, the mRNA and protein expressions of S1PR3, ROCK1 and ROCK2 exhibited no significant difference in group B but were remarkably decreased in groups C, D, E and F (P< 0.05), most significantly in group E, with the inhibition rates of the mRNA and protein expressions of S1PR3 of (34.2±2.9) and (77.7±4.7)%, those of ROCK1 of (33.3±1.4) and (51.1±7.3)%, and those of ROCK2 of (30.8±3.6) and (58.32±5.5)%, respectively. The mRNA and protein expressions of eNOS in group A showed no significant difference from those in groups B, C, D and E (P>0.05) but remarkably lower than those in group F (P< 0.05). Compared with group F, the mRNA and protein expressions of S1PR3, ROCK1 and ROCK2 were not significantly different from those in group E (P>0.05) but markedly increased in groups A, B, C and D (P< 0.05), while those of eNOS remarkably decreased in groups A, B, C, D and E (P< 0.05).
The three constructed lentiviral vectors carrying siRNA targeting different loci of the S1PR3 gene could significantly inhibit the expression of S1P3 as well as RhoA/Rho kinase signaling pathways in the CCSM cells of SHT rats, and the vector carrying siRNA3 exhibited the highest inhibitory effect.
筛选携带小干扰RNA(siRNA)的慢病毒载体,该载体可特异性下调自发性高血压(SHT)大鼠海绵体平滑肌(CCSM)细胞中鞘氨醇-1-磷酸受体3(S1PR3)的基因表达,并研究该载体对SHT大鼠CCSM细胞中ROCK1、ROCK2和内皮型一氧化氮合酶(eNOS)信号通路的影响。
以大鼠S1PR3 mRNA序列为干扰靶点,设计并合成3对靶向S1PR3的siRNA序列(siRNA1、2和3)及1对阴性对照,然后构建并包装成慢病毒载体。体外培养SHT大鼠和Wistar-Kyoto(WKY)大鼠的CCSM细胞,随机分为A组(SHT未转染对照组)、B组(SHT转染并携带阴性对照病毒)、C组(SHT转染并携带靶向S1PR3的siRNA1)、D组(SHT转染并携带靶向S1PR3的siRNA2)、E组(SHT转染并携带靶向S1PR3的siRNA3)和F组(WKY未转染对照组)。以感染复数(MOI)=60,用慢病毒载体转染SHT大鼠的CCSM细胞,然后通过逆转录聚合酶链反应(RT-PCR)和蛋白质免疫印迹法检测SHT和WKY大鼠CCSM细胞中绿色荧光蛋白(GFP)的表达以及S1PR3、ROCK1、ROCK2和eNOS的mRNA和蛋白表达。
基因测序证明慢病毒载体构建成功。B、C、D和E组大鼠CCSM细胞的转染效率>80%。与A组相比,B组S1PR3、ROCK1和ROCK2的mRNA和蛋白表达无显著差异,但C、D、E和F组显著降低(P<0.05),E组最显著,S1PR3的mRNA和蛋白表达抑制率分别为(34.2±2.9)%和(77.7±4.7)%,ROCK1的分别为(33.3±1.4)%和(51.1±7.3)%,ROCK2的分别为(30.8±3.6)%和(58.32±5.5)%。A组eNOS的mRNA和蛋白表达与B、C、D和E组无显著差异(P>0.05),但显著低于F组(P<0.05)。与F组相比,E组S1PR3、ROCK1和ROCK2的mRNA和蛋白表达无显著差异(P>0.05),但A、B、C和D组显著升高(P<0.05),而A、B、C、D和E组eNOS的mRNA和蛋白表达显著降低(P<0.05)。
构建的3种携带靶向S1PR3基因不同位点siRNA的慢病毒载体可显著抑制SHT大鼠CCSM细胞中S1P3的表达以及RhoA/ Rho激酶信号通路,携带siRNA3的载体抑制作用最强。